Envoy Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Envoy Medical, Inc. (COCH) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Dec 2021
Operating Activities
Net Income-22.45-29.92-15.92-8.68
Depreciation & Amortization0.170.130.080.07
Stock Based Compensation0.001.580.000.00
Change in Working Capital-0.64-0.98-0.16-0.08
Change in Accounts Receivable-0.57-0.030.05-0.02
Change in Inventory-0.38-0.01-0.190.06
Change in Accounts Payable-0.020.550.340.23
Change in Other Working Capital0.3314.05-0.361.75
Other Operating Activities4.9714.057.201.75
Net Cash from Operating Activities-17.95-17.09-8.81-6.94
Investing Activities
Capital Expenditures-0.98-0.15-0.22-0.13
Net Cash from Investing Activities-0.98-0.15-0.22-0.13
Financing Activities
Debt Repayment19.08-0.560.000.00
Common Stock Issued3.560.110.000.00
Dividends Paid-2.450.000.000.00
Other Financing Activities0.00-0.560.090.06
Net Cash from Financing Activities20.2021.288.098.06
Summary
Effect of Forex Changes on Cash0.000.00-0.01-0.01
Net Change in Cash1.274.04-0.941.00
Cash at Beginning of Period4.220.181.120.13
Cash at End of Period5.484.220.181.12
Free Cash Flow-18.93-17.24-9.02-7.06